DRKS00019844招募中不适用
Molecular Fingerprinting in Cancer Detection
udwig-Maximilians-Universität München (LMU)0 个研究点目标入组 38,000 人开始时间: 2020年4月17日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 38,000
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 one（—）
- 性别
- All
入选标准
- •Informed consent, = 18 years, healthy subject, or one of the eligible benign or malignant diseases.
排除标准
- •Multiple cancers, any cancer therapy within the last two years, no blood draw possible, participant noncompliance
研究者
相似试验
已完成
不适用
Molecular Fingerprinting in CancerC34C61C50C67C56C00-C14C18C22C25Malignant neoplasm of bronchus and lungMalignant neoplasm of prostateMalignant neoplasm of breastMalignant neoplasm of bladderMalignant neoplasm of ovaryMalignant neoplasms of lip, oral cavity and pharynxMalignant neoplasm of colonMalignant neoplasm of liver and intrahepatic bile ductsMalignant neoplasm of pancreasDRKS00013217udwig-Maximilians Universität München, Fakultät für Physik,3,479
进行中（未招募）
Unknown
PROMINENT Smoking Cessation Studyung cancerCancerISRCTN12925323niversity of Manchester200
招募中
不适用
oninvasive detection of circulating tumor DNA for disease classification and monitoring in patients with brain tumors.C71C72Malignant neoplasm of brainMalignant neoplasm of spinal cord, cranial nerves and other parts of central nervous systemDRKS00015307niversitätsklinikum Freiburg200
招募中
不适用
Development of molecular diagnostic markers using oral fluid for diagnosis of periodontitis in diabetesDiseases of the musculo-skeletal system and connective tissueKCT0001023Asan Medical Center24
招募中
不适用
The Cancer Molecular Screening and Therapeutics (MoST) Program-ScreeningCancer - Any cancerCancerACTRN12616000908437niversity of Sydney7,628